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Abstract
Background: Abnormal branched myofibers within skeletal muscles are commonly found in diverse animal models
of muscular dystrophy as well as in patients. Branched myofibers from dystrophic mice are more susceptible to
break than unbranched myofibers suggesting that muscles containing a high percentage of these myofibers are
more prone to injury. Previous studies showed ubiquitous over-expression of mouse olfactory receptor 23 (mOR23),
a G protein-coupled receptor, in wild type mice decreased myofiber branching. Whether mOR23 over-expression
specifically in skeletal muscle cells is sufficient to mitigate myofiber branching in dystrophic muscle is unknown.
Methods: We created a novel transgenic mouse over-expressing mOR23 specifically in muscle cells and then bred
with dystrophic (mdx) mice. Myofiber branching was analyzed in these two transgenic mice and membrane
integrity was assessed by Evans blue dye fluorescence.
Results: mOR23 over-expression in muscle led to a decrease of myofiber branching after muscle regeneration in
non-dystrophic mouse muscles and reduced the severity of myofiber branching in mdx mouse muscles. Muscles
from mdx mouse over-expressing mOR23 significantly exhibited less damage to eccentric contractions than control
mdx muscles.
Conclusions: The decrease of myofiber branching in mdx mouse muscles over-expressing mOR23 reduced the
amount of membrane damage induced by mechanical stress. These results suggest that modifying myofiber
branching in dystrophic patients, while not preventing degeneration, could be beneficial for mitigating some of
the effects of the disease process.
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Background
Duchenne muscular dystrophy (DMD) is an X-linked
disease due to the absence of dystrophin in muscle [1]
that affects about one in every 3500 boys [2]. The lack of
dystrophin in DMD patients leads to progressive muscle
degeneration and weakness resulting in death from heart
or respiratory failure during the third decade of life.
There is currently no curative treatment for this disease.
One characteristic of dystrophic muscle is the presence
of myofibers with an abnormal branching cytoarchitecture
[3, 4]. These aberrant myofibers called branched myofibers
or split myofibers contain one or more offshoots of daugh-
ter myotubes contiguous with the parent myofiber.
Myofiber branching negatively impacts dystrophic mus-
cles as demonstrated using extensor digitorum longus
(EDL) muscles from dystrophin-deficient mdx mice. Un-
branched and branched myofibers isolated from mdx EDL
muscles were subjected to Ca2+-force activation. Branched
myofibers broke before reaching maximal calcium activa-
tion, whereas unbranched myofibers were able to sustain
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maximal force without any break [5]. When EDL muscles
from mdx mice were eccentrically contracted (EC), then
incubated in Evans blue dye (EBD), approximately 70 % of
the isolated branched myofibers showed EBD uptake at
branch points indicating membrane damage, while no dye
was observed in unbranched myofibers [5]. Following Ca2
+ osmotic stress, branched myofibers from mdx muscles
also exhibited a higher number of osmotic-induced Ca2+
sparks than unbranched myofibers [6]. Together, these
data indicate that myofiber branching impairs multiple
aspects of muscle physiology in dystrophic muscles.
This leads to the question of how to reduce myofiber
branching in dystrophic muscles in order to improve
muscle physiology.
We recently identified mouse olfactory receptor 23
(mOR23, olfr16) as a molecule regulating myofiber
branching in mouse muscles [7]. Olfactory receptors
(OR) are G protein-coupled receptors mainly found in
neurons of the olfactory epithelium where they have
been extensively studied, but they are also expressed
in non-olfactory tissues such as the brain, tongue,
testis, spleen, prostate, kidney, and smooth and skeletal
muscle [8, 9]. OR serve as specialized chemosensors and
are activated by exogenous ligands known as odorants in
olfactory neurons or by endogenous ligands in non-
olfactory tissues. Endogenous OR ligands have only been
identified in non-olfactory tissues for olfr78 in the carotid
body, kidney, peripheral vasculature, and prostate [9–11].
Mouse muscles electroporated with a plasmid expressing
mOR23 under the control of a ubiquitous promoter con-
tained fewer branched myofibers and fewer branches per
myofiber [7]. In the skeletal muscle, several types of cells
are important for muscle regeneration such as neutrophils
[12], macrophages [13], and fibroblasts [14] in addition to
muscle stem cells [15]. Since mOR23 was ubiquitously
over-expressed, whether mOR23 was required specifically
in muscle cells to regulate myofiber branching could not
be addressed in these experiments. To directly address the
role of mOR23 in muscle cells during myofiber branching,
we created a novel transgenic mouse over-expressing
mOR23 under the control of a specific muscle promoter
[16]. In-depth quantitative analyses of myofiber branching
in these transgenic mice demonstrated that myofiber
branching was reduced after chemically induced muscle
injury. Subsequently, these mice were bred with mdx mice
to determine whether muscle-specific over-expression
of mOR23 was also beneficial in the context of repeated
cycles of muscle degeneration/regeneration. We observed
decreased myofiber branching in mdx mice over-
expressing mOR23 resulting in less membrane damage
of the dystrophic muscles after mechanical stress. To-
gether, these results indicate that expression of mOR23
specifically in skeletal muscle is sufficient to decrease the
incidence of myofiber branching after muscle injury.
Methods
Mice
Wild type (C57BL/6) and mdx (C57BL/10) mice were
purchased from The Jackson Laboratory (Bar Harbor, ME,
USA). To create mOR23 transgenic mice, the mOR23 gene
was excised from pME-18S [17] using XbaI and BamHI re-
striction enzymes and ligated into pBSX-HSAvpA [18] pre-
viously cut with NotI and XbaI restriction enzymes. The
resulting plasmid was named pHSA.mOR23 and cut using
PvuI and KpnI restriction enzymes. The subsequent frag-
ment was used by the Emory Transgenic Core to produce
two independent lines of mOR23 transgenic mice, TG1 and
TG2. TG1 was bred with mdx mice to create transgenic
mdx mice over-expressing mOR23 (Tg-mdx). Female and
male mice were used in all experiments at 8–12 weeks of
age unless described otherwise. Experiments involving
animals were performed in accordance with approved
guidelines and ethical approval from Emory University’s
and Georgia Institute of Technology’s Institutional Animal
Care and Use Committees.
Quantitative real-time PCR
Total RNA from gastrocnemius muscles was isolated
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s protocol. For each sample,
500 ng of RNA was digested with DNAseI (Invitrogen) to
remove any DNA contaminants and cDNA synthesis was
performed by M-MLV reverse-transcriptase (Invitrogen).
Using a real-time (RT) PCR system (StepOnePlus, Applied
Biosystem, Foster City, CA, USA), the relative levels of
mOR23 were determined by the ΔΔCt method [19] and
normalized to the housekeeping gene HPRT1. Primers were
purchased from SA Biosciences (Valencia, CA, USA)
(mOR23: PPM60724B, HPRT1: PPM03559E). All reactions
were performed in duplicate.
Muscle injury
BaCl2
Mice were anesthetized with an intraperitoneal injection
of a solution containing 80 mg/kg ketamine HCl/5 mg/kg
xylazine and subcutaneously injected with an analgesic
(0.1 mg/kg buprenorphine) before and after muscle injury.
Injury was induced in gastrocnemius muscles of anesthe-
tized mice by injection of 40 μl of 1.2 % BaCl2 [20]. Mus-
cles were collected 2–3 weeks after the injury and either
snap frozen in liquid nitrogen or enzymatically digested
for isolation of single myofibers.
Eccentric contraction
The day before the eccentric contraction protocol, mice
were intraperitoneally injected with EBD (Sigma-Aldrich)
(100 μL of 1 % EBD in PBS per 10-g body weight). The fol-
lowing day, mice were anesthetized by intraperitoneal injec-
tion of a ketamine/xylazine cocktail (90 mg/kg ketamine,
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15 mg/ml xylazine), with supplemental doses as necessary.
The left plantaris and soleus muscles were ablated and a 4-
0 suture tied around the Achilles tendon at the calcaneus.
The insertion of the tendon was clipped from the calca-
neus, leaving a small bone chip to anchor the suture. The
knee was immobilized by a spring clamp fixed to the fem-
oral condyles, and the gastrocnemius complex was attached
to a force-reporting servo motor (Aurora Scientific, Aurora,
ON, Canada). The sciatic nerve was exposed and mounted
on bipolar stainless steel hook electrodes. A series of twitch
contractions was used to determine the stimulation voltage
and muscle length (L0) required for maximal active force
production. Muscles were stimulated using constant
current, determined for each animal as twice the current
required (700–1500 uA) to yield maximum twitch force. L0
was determined from twitches by adjusting the muscle
length to maximize active tension. The lengthening activa-
tion protocol consisted of 300 stimulations, each 500 ms of
0.1-ms pulses delivered at 70 Hz and 2× maximal voltage.
The muscle was held isometric for 200 ms at L0 − 10 % op-
timal fiber length (Lf ), stretched to L0 + 10 % Lf over
200 ms, and held for 200 ms. The muscle was returned to
L0 − 10 % Lf after relaxation with 500-ms rest between acti-
vations. At the end of the protocol, muscles were collected
and snap frozen in liquid nitrogen.
Single myofiber isolation
Single myofibers were isolated from gastrocnemius mus-
cles as previously described [20]. Briefly, muscles were
gently dissected, added to a tube containing 4000 U col-
lagenase type I (Worthington Biochemical, Lakewood
Township, NJ, USA). The tube was rocked at 26 rpm in
an Enviro-Genie (Scientific Industries, Bohemia, NY,
USA) set at 37 °C. Wild type muscles were digested for
90 min and for up to 120 min for mdx and Tg-mdx
muscles. After incubation in collagenase, single myofi-
bers were washed and transferred into a Matrigel (BD
Pharmigen, San Diego, CA, USA)-coated 24-well plate
using a fire-polished Pasteur pipette. Isolated myofibers
were allowed to settle for 30 min in the well before the
plates were centrifuged at 1100g for 20 min and then
fixed with 3.7 % formaldehyde for 10 min. A total of 471
and 475 myofibers were isolated for mdx and Tg-mdx
mice, respectively, and between 496 and 828 for wild
type ( WT), TG1, and TG2 BaCl2-injured mice.
Single myofiber analysis
Single myofibers were stained with 1 μg/ml 4′,6-diamidino-
2-phenylindole (DAPI, Sigma-Aldrich, St Louis, MO, USA)
for 1 min to visualize nuclei. Myofibers were visualized
using an Axiovert 200M microscope (Carl Zeiss Micros-
copy, Thornwood, NY, USA), and images were acquired
using a 10× or 20× Plan-Neofluar objective (Carl Zeiss Mi-
croscopy) and camera (QImaging, Surrey, BC, Canada)
with OpenLab 5.50 software (PerkinElmer, Waltham, MA,
USA). All images were uniformly processed for size, bright-
ness, and contrast using Photoshop CS6 (Adobe Systems,
San Jose, CA, USA). Myofibers with at least four centrally
located nuclei in a row were considered regenerated.
Branches were grouped into three morphologic categories:
bifurcated, split, and process although the significance
of these different types of branches is not well under-
stood [6, 20, 21].
Histological analysis
Serial 12-μm cryostat sections were obtained throughout
frozen muscles. For histological analyses, sections were
stained with hematoxylin (Thermo Fisher Scientific,
Waltham, MA, USA) and eosin (Sigma-Aldrich) stained
sections using ImageJ (NIH, Bethesda, MD, USA). For
all tissue section studies, three to four representative
sections imaged at ×200 magnification were analyzed
from gastrocnemius muscles. For EBD quantification,
images were acquired from the same anatomic region in
three to four different sections and the EBD fluorescence
of each image was measured as pixel intensity using
Image J. All images were acquired using an Axioplan
microscope with a 0.5 NA 20× Plan-Neofluar objective
(Carl Zeiss Microscopy) and charge-coupled device cam-
era (Carl Zeiss Microscopy) with Scion Image 1.63
(Scion Corporation, Frederick, MD, USA). All images
were uniformly processed for size, brightness, and con-
trast using Photoshop CS6 (Adobe).
Statistical analyses
To determine statistical significance for two groups,
comparisons were made using an unpaired or paired
Student’s t test. Chi-square tests were performed for the
analysis of the number of branches per myofiber. The
significance of results from multiple groups was evalu-
ated by a one-way analysis of variance (ANOVA) with
Bonferroni’s post-test. The Friedman test with Dunn’s
post-test was used to analyze EBD fluorescence in muscle
sections. Statistical analyses were performed using Graph-
Pad Prism v.6 (GraphPad Software, La Jolla, CA, USA). A
p value <0.05 was considered significant.
Results
mOR23 transgenic mice
To determine the role of mOR23 in regulating myofiber
branching specifically in muscle cells, we created a novel
transgenic mouse over-expressing mOR23 under the
control of the human skeletal actin (HSA) promoter, a
muscle-specific promoter (Fig. 1a). Two independent lines
of transgenic mice (TG1 and TG2) were produced and
tested for mOR23 over-expression. As shown in Fig. 1b,
mOR23 messenger RNA (mRNA) was over-expressed in
both lines compared to control mice (WT). Since the
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levels of mOR23 mRNA in TG1 were more than 10 times
the levels found in TG2, we mainly focused our subse-
quent experiments on TG1.
Analysis of myofiber branching in isolated myofibers
To compare myofiber branching, single myofibers were
analyzed rather than transverse sections of muscle tissue
since all branches along the length of isolated myofibers
can be easily identified. Single myofibers were isolated
from enzymatically digested gastrocnemius muscles,
then fixed and stained with DAPI to visualize nuclei.
Myofibers were examined using phase contrast and
fluorescence microscopy. Myofibers with at least four
centrally located nuclei in a row were scored as regen-
erated. Branches were grouped into three morphologic
categories (Fig. 2a–c): bifurcated, split, and process as
previously described [20]. Myofibers may have mul-
tiple branch types as is frequently encountered in aged
mdx muscles (Fig. 2d).
Muscle-specific expression of mOR23 decreases myofiber
branching in chemically injured mouse muscles
Under basal conditions in young mice, very low levels of
myofiber branching (1 %) occur in muscle but the fre-
quency increases dramatically in response to muscle re-
generation [7, 20, 22–24]. Therefore, we determined
whether mOR23 over-expression in muscle cells was
sufficient to regulate muscle regeneration and myofiber
branching in chemically injured mouse muscles. To as-
sess whether mOR23 protein would be over-expressed
in differentiating TG1 muscle cells during regeneration,
we analyzed muscle cells in vitro so as to assay mOR23
specifically in muscle cells in the absence of other cell
types. mOR23 protein levels were increased by ~40 %
in TG1 compared to WT at 48 h of differentiation
(Additional file 1: Figure S1). Subsequently, gastrocnemius
muscles of WT and TG1 were injured using barium chlor-
ide (BaCl2) to determine whether the muscle-specific
over-expression of mOR23 affected muscle regeneration.
We first analyzed the myofiber cross-sectional area (CSA)
of uninjured and injured gastrocnemius muscles. Two
weeks after injury, no significant difference in myofiber
CSA was observed between WTand TG1 muscles (Fig. 3a,
b) suggesting similar overall muscle regenerative ability.
To analyze myofiber branching, single myofibers were iso-
lated from muscles 3 weeks post-injury. As a control,
myofibers were also isolated from uninjured muscles. The
same number of branched myofibers (~1 %) was found in
uninjured WT or TG1 muscles (data not shown). No
significant difference in the percentage of regenerated
myofibers was observed between WT and TG1 (Fig. 3c)
indicating a similar amount of muscle damage in both
mice. Remarkably, the percentage of branched regenerated
myofibers and the number of branches per branched myo-
fiber were significantly decreased in TG1 compared to
WT (Fig. 3d, e). No significant difference was observed
among the three types of branches between WT and TG1
(Additional file 2: Figure S2). To validate these results, we
also analyzed myofiber branching in the gastrocnemius
muscles of TG2 mice after muscle injury. Similar to the
results obtained with TG1, we observed no difference in
the percentage of regenerated myofibers between WT and
TG2 (Additional file 3: Figure S3A) but the percentage of
branched regenerated myofibers was decreased in TG2
(Additional file 3: Figure S3B). However, the number of
branches per branched myofiber was not significantly dif-
ferent between WT and TG2 (Additional file 3: Figure
S3C) as it was for TG1 (Fig. 3e). This discrepancy in the
number of branches between the two transgenic mouse
lines may be due to the fact that mOR23 mRNA levels
were 10 times higher in TG1 than in TG2 (Fig. 1b). Over-
all, these data indicate that mOR23 expression in muscle
cells is sufficient to regulate myofiber branching during
muscle regeneration.
Fig. 1 mOR23 expression in transgenic mouse muscles. a Schematic
representation of the construct used to drive muscle-specific
expression of mOR23. mOR23 was fused with rhodopsin (RHO)
to increase mOR23 cell surface expression. HSA human α-skeletal actin.
b mOR23 RNA levels were greatly increased in the gastrocnemius
muscles of two different transgenic (TG) mouse lines compared to
wild type (WT): TG1 (3302 ± 1141), TG2 (218 ± 21). Data are mean ± SEM
with n= 4–6 for each genotype
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mOR23 over-expression reduces myofiber branching in
dystrophic mouse muscles
We next bred TG1 with mdx mice to create Tg-mdx to
determine whether muscle-specific over-expression of
mOR23 would also decrease myofiber branching in the
context of the repeated cycles of muscle degeneration/
regeneration found in mdx mice [25, 26]. The histology
of gastrocnemius muscles from mdx and Tg-mdx mice
were first compared. For both genotypes at 8 weeks of
age, a similar heterogeneity in myofiber sizes was observed
in muscle sections indicating no gross difference in muscle
regenerative ability (Fig. 4a). Since we previously demon-
strated that the percentage of branched myofibers in
gastrocnemius muscles rapidly increased in mdx mice
Fig. 2 Phase-contrast image of branched myofibers. a–c Phase-contrast images of the three branch types studied: bifurcated (a), split (b), and
process (c). Bar = 100 μm. d Phase-contrast image of a highly branched myofiber from a 15-week-old mdx mouse. Bar = 250 μm
Fig. 3 mOR23 over-expression decreases myofiber branching after muscle regeneration. a Myofiber cross-sectional areas (CSA) of WT and TG1
gastrocnemius muscles were comparable before injury and after 2 weeks of regeneration. b Representative images of injured WT and TG1
muscles after 2 weeks of regeneration. Bar = 100 μm. c The percentage of regenerated myofibers was not significantly different in WT and TG1
muscles 3 weeks after muscle injury but TG1 muscles contained significantly less branched regenerated myofibers than WT muscles (d). e The
number of branches per branched myofiber was also significantly decreased in injured TG1 muscles compared to WT (chi-square = 21.6, df = 3).
n = 94–196 myofibers isolated per genotype and mouse. Data are mean ± SEM and n = 4–6 mice for each genotype with *p < 0.05
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between 3 and 10 weeks of age reaching ~90 % [20], single
myofibers from gastrocnemius muscles of mdx and
Tg-mdx mice were analyzed at 5, 8, and 15 weeks of
age. At each age, the percentage of regenerated myofibers
was not significantly different between both genotypes
(Fig. 4b) indicating a similar amount of muscle damage
occurred in both dystrophic lines. The percentage of re-
generated myofibers that were branched was significantly
decreased in Tg-mdx at 5 and 8 weeks of age but not at
15 weeks of age (Fig. 4c). Interestingly, the number of
branches per branched myofiber was significantly reduced
in 8- and 15-week-old Tg-mdx compared to mdx mice but
not at 5 weeks of age. These results suggest that at 5 weeks
of age when a low amount of damage is occurring in dys-
trophic muscles [25, 26], mOR23 over-expression only
acts to decrease the likelihood of a myofiber becoming
branched. In contrast, at 15 weeks of age when severe
muscle degeneration already occurred in mdx mice
[25, 26], mOR23 over-expression cannot influence
whether a myofiber becomes branched or not but can
decrease the number of branches that arise per damaged
myofiber. At the three ages analyzed, the three types of
branches were globally equally distributed between mdx
and Tg-mdx (Additional file 4: Figure S4). Overall, these
findings demonstrate that mOR23 over-expression does
not protect against muscle degeneration induced by the
lack of dystrophin but can reduce the severity of myofiber
branching arising in dystrophic muscles.
mOR23 over-expression protects dystrophic muscle
against mechanical damage
Branched mdx myofibers are more fragile when subjected
to mechanical stress than unbranched mdx myofibers
[5, 6, 21, 27, 28]. Since Tg-mdx mice displayed less se-
vere myofiber branching than control mdx mice, we
subsequently assessed the membrane integrity of Tg-
mdx and mdx mouse muscles in response to in vivo
mechanical stress. Eight-week-old mice were used in
this experiment since both the percentage of branched
myofibers and the number of branches per myofiber
were significantly decreased in Tg-mdx myofibers com-
pared to mdx. To determine changes in membrane in-
tegrity in response to mechanical stress, we used Evans
blue dye (EBD) as an in vivo marker of myofiber damage
as EBD penetrates into myofibers in response to disrup-
tion of the sarcolemma [5]. Damaged myofibers are then
readily identifiable by the fluorescence emitted by the dye.
To induce muscle injury, gastrocnemius muscles were
subject to 300 eccentric contractions (EC) of 10 % optimal
fiber length. Peak isometric force was similar in mdx
(11.3 ± 3.2 N/g) and Tg-mdx (8.59 ± 4.2 N/g, p = 0.22),
and lengthening resulted in similar eccentric forces
(mdx 15.4 ± 4.1 N/g; Tg-mdx 12.4 ± 6.2 N/g; p = 0.35).
Repeated activation resulted in dramatic and rapid loss
of contractile capacity, with declines of 85 ± 4.9 % in
mdx and 74 ± 18 % in Tg-mdx after the first 100 acti-
vations (p = 0.19 between genotypes). Muscles were
Fig. 4 Myofiber branching is decreased in mdx muscles over-expressing mOR23. a Representative images of 8-week-old mdx and Tg-mdx
gastrocnemius muscles. Bar = 100 μm. b The percentage of regenerated myofibers was not significantly different between mdx and Tg-mdx
muscles at the three ages (5, 8, and 15 weeks) studied. c Tg-mdx muscles had significantly less branched regenerated myofibers than mdx
muscles at 5 and 8 weeks of age. d The number of branches per branched myofiber was also significantly decreased in Tg-mdx muscles compared to
mdx at both 8 weeks (chi-square = 12.3, df = 3) and 15 weeks of age (chi-square = 13.9, df= 3). n = 32–103 myofibers isolated per age and mouse. Data
are mean ± SEM and n = 3–4 for each genotype at each age with *p < 0.05
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collected 30 min after the last contraction to let the
dye penetrate damaged myofibers. Muscle sections of
control contralateral and EC muscles were then visual-
ized for EBD fluorescence in both genotypes (Fig. 5a),
and the pixel intensity was quantified (Fig. 5b). Since
muscle physiology varies considerably between animals,
we compared EBD pixel intensity between contralateral
and EC muscles for each mouse. We observed a higher in-
crease of EBD pixel intensity in mdx muscles after eccen-
tric contractions compared to Tg-mdx muscles (Fig. 5b)
indicating that Tg-mdx muscles were more resistant to
sarcolemmal damage in response to eccentric contractions
These data suggest that the over-expression of mOR23 in
mdx mice protects muscles against mechanical stress by
decreasing the overall number of branches in myofibers.
Discussion
The results reported here expand previous studies of
mOR23 in muscle tissue [7] and give insights into the
formation of branched myofibers, which are detrimental
for normal muscle physiology. One significant finding of
this study is that following acute muscle injury, myofiber
branching was decreased in transgenic mice over-ex-
pressing mOR23 specifically in muscle cells. Depending
on the level of mOR23 over-expression, the number of
branches per branched myofiber was also reduced. These
results suggest that putative endogenous ligand(s) of
mOR23 [7, 29] produced in response to muscle damage
were not limiting under these conditions. Another import-
ant finding is that when mOR23 was over-expressed in
myofibers in a dystrophic environment with ongoing cy-
cles of myofiber degeneration/regeneration, myofiber
branching was also decreased. These are the first studies
to show that myofiber branching can be decreased in dys-
trophic muscles. Depending on the amount of damage
that occurred in dystrophic mice with age, the parameters
of the myofiber branching varied. At 8 weeks of age, dys-
trophic muscles were characterized by a reduction in the
percentage of branched myofibers as well as a decrease of
the number of branches per branched myofiber. However,
at 15 weeks of age only the number of branches per
branched myofiber was decreased. These differences could
be due to changes in the production of putative endogen-
ous mOR23 ligand(s) or to derangements in cell signaling
pathways with age in dystrophic mice [30, 31]. Taken to-
gether our data indicate that mOR23 over-expression in
muscle cells is sufficient to reduce myofiber branching in
mice suggesting that biologic processes acting within
muscle cells are important for determining whether
branches form or not upon muscle injury.
Previous studies of dystrophic muscles indicated that
myofiber branching is detrimental for normal muscle
physiology [5, 6, 21, 27, 28]. Branched myofibers tends
to break at the branch point thereby decreasing the ability
of myofibers to properly contract [5, 21]. Another key
finding in our studies was that a decrease of myofiber
branching in dystrophic muscle via the over-expression of
mOR23 in muscle cells improved membrane integrity in
response to mechanical stress induced by a stretch of ec-
centric contractions. These results suggest that modifying
myofiber branching in dystrophic patients, while not
preventing degeneration, could be beneficial for miti-
gating some of the effects of the disease process. Such
a therapy could be used in combination with other
disease-modifying strategies currently under develop-
ment [32, 33].
Olfactory receptor activation leads to an increase
in cyclic adenosine monophosphate (cAMP) synthesis
through the activation of adenylate cyclase type III
via a G protein-coupled cascade in the neurons [8], sperm
[34], and kidney [35] as well as skeletal muscle [7]. In
olfactory neurons, this increase in cAMP can regulate
Fig. 5 Over-expression of mOR23 in mdx muscles protects against membrane injury after eccentric muscle contractions. a Representative images
of gastrocnemius muscles from mdx and Tg-mdx mice which underwent eccentric contraction (EC) or not (CTL, contralateral muscle). Evans blue
dye (EBD) fluorescence identified myofibers with increased membrane permeability. Bar = 100 μm. b mdx muscles were significantly more
permeable to EBD after EC than Tg-mdx muscles. Each line represents the CTL and EC muscle of one mouse, n = 7 for each genotype
with *p < 0.05
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expression of adhesion molecules such as Kirrel3 or
EphrinA5 [36], neuropilin-1 which plays versatile roles
in angiogenesis, cell survival and migration [37], and
multiple ion channels [8]. Myofiber branching has been
postulated to arise from aberrant muscle cell fusion
[6, 20, 21, 38]. Previous studies of mOR23 function in
vitro revealed that cell migration, cell-cell adhesion,
and formation of multinucleated myotubes were signifi-
cantly inhibited with loss of mOR23 by small interfering
RNA (siRNA) or increased by its over-expression [7] sug-
gesting that mOR23 may regulate cell fusion through
downstream migration and adhesion molecules. However,
no downstream effectors of mOR23 in vitro or in vivo
have been identified to date.
Conclusions
mOR23 signaling within muscle cells may serve as an
effective pharmacologic target for improving muscle
architecture and physiology in dystrophic patients. The
use of small molecules to activate downstream pro-
cesses normally induced by mOR23 signaling in muscle
cells could overcome any potential limitations in the
amount of putative endogenous ligand(s) produced at
different stages of the dystrophic disease process. Add-
itional studies are needed to identify other molecules
and pathways that synergize with mOR23-dependent
pathways to further decrease myofiber branching in
dystrophic muscles.
Additional files
Additional file 1: Figure S1. mOR23 is over-expressed during myogenesis
in TG1 myoblasts. (A) Immunoblot revealed that mOR23 levels increased after
48 h of myoblast differentiation in vitro but the levels of mOR23 were higher
in TG1 muscle cells than in WT. (B) Quantification of mOR23 levels in
differentiating muscle cells in vitro. Data are mean ± SEM; n = 3 with
*p < 0.05.
Additional file 2: Figure S2. Quantification of branch types in WT and
TG1. No significant difference was observed between WT and TG1
myofibers for the distribution of the bifurcated, split, and process branch
types 3 weeks after muscle injury. n = 27–88 branched myofibers isolated
per mouse. Data are mean ± SEM and n = 4–6 mice for each genotype.
Additional file 3: Figure S3. Myofiber branching is also decreased in
mOR23 transgenic mouse line 2 after muscle regeneration. (A) The
percentage of regenerated myofibers in gastrocnemius muscles was not
significantly different in WT and TG2 mice 3 weeks after muscle injury
but TG2 muscles had significantly fewer branched regenerated myofibers
than WT muscles (B). (C) The number of branches per branched myofiber
was not significantly decreased in injured TG muscles compared to WT
muscles (chi-square = 2.51, df = 3). n = 108–196 myofibers isolated per
genotype and mouse. Data are mean ± SEM and n = 4 mice for each
genotype with *p < 0.05.
Additional file 4: Figure S4. Quantification of branch types in mdx and
Tg-mdx. Except for a significant increase of the split branch type in mdx
compared to Tg-mdx at 5 weeks of age, the types of branches did not
differ between mdx and Tg-mdx. n = 7–64 branched myofibers isolated
per age and mouse. Data are mean ± SEM and n = 3–4 for each genotype
at each age with *p < 0.05.
Abbreviations
cAMP: cyclic adenosine monophosphate; CSA: cross-sectional area;
DAPI: 4′,6-diamidino-2-phenylindole; DMD: Duchenne muscular dystrophy;
EBD: Evans blue dye; EC: eccentric contraction; EDL: extensor digitorum
longus; HSA: human skeletal actin; mOR: mouse olfactory receptor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CP and GKP conceived and designed the study. CP performed the research.
CP and TJB performed the muscle physiology experiments. CP and GKP
analyzed the research and wrote the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
pBSX-HSAvpA is a gift from Dr. Jeff Chamberlain via Dr. Edna Hardeman. This
work was supported by grants to GKP from the Muscular Dystrophy
Association (#186852) and NIH (AR061267).
Author details
1Department of Pharmacology, Emory University, Atlanta, GA, USA. 2School
of Applied Physiology, Georgia Institute of Technology, Atlanta, GA, USA.
3Present address: Department of Genetics, Stanford University, Stanford, CA,
USA. 41510 Clifton Road, Room 5024, Atlanta, GA 30322, USA.
Received: 19 October 2015 Accepted: 5 January 2016
References
1. Hoffman EP, Brown Jr RH, Kunkel LM. Dystrophin: the protein product of
the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919–28.
2. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al.
Diagnosis and management of Duchenne muscular dystrophy, part 1:
diagnosis, and pharmacological and psychosocial management. Lancet
Neurol. 2010;9(1):77–93. doi:10.1016/S1474-4422(09)70271-6.
3. Swash M, Schwartz MS. Implications of longitudinal muscle fibre splitting
in neurogenic and myopathic disorders. J Neurol Neurosurg Psychiatry.
1977;40(12):1152–9.
4. Ontell M. Muscle fiber necrosis in murine dystrophy. Muscle Nerve.
1981;4(3):204–13. doi:10.1002/mus.880040306.
5. Head SI. Branched fibres in old dystrophic mdx muscle are associated with
mechanical weakening of the sarcolemma, abnormal Ca2+ transients and a
breakdown of Ca2+ homeostasis during fatigue. Exp Physiol. 2010;95(5):641–56.
doi:10.1113/expphysiol.2009.052019.
6. Lovering RM, Michaelson L, Ward CW. Malformed mdx myofibers have
normal cytoskeletal architecture yet altered EC coupling and stress-induced
Ca2+ signaling. Am J Physiol Cell Physiol. 2009;297(3):C571–80.
doi:10.1152/ajpcell.00087.2009.
7. Griffin CA, Kafadar KA, Pavlath GK. MOR23 promotes muscle regeneration
and regulates cell adhesion and migration. Dev Cell. 2009;17(5):649–61.
doi:10.1016/j.devcel.2009.09.004.
8. Kang N, Koo J. Olfactory receptors in non-chemosensory tissues. BMB Rep.
2012;45(11):612–22.
9. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al.
Olfactory receptor responding to gut microbiota-derived signals plays a role
in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A.
2013;110(11):4410–5. doi:10.1073/pnas.1215927110.
10. Neuhaus EM, Zhang W, Gelis L, Deng Y, Noldus J, Hatt H. Activation of an
olfactory receptor inhibits proliferation of prostate cancer cells. J Biol Chem.
2009;284(24):16218–25. doi:10.1074/jbc.M109.012096.
11. Chang AJ, Ortega FE, Riegler J, Madison DV, Krasnow MA. Oxygen
regulation of breathing through an olfactory receptor activated by lactate.
Nature. 2015;527(7577):240–4. doi:10.1038/nature15721.
12. Teixeira CF, Zamuner SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA,
Fernandes I, et al. Neutrophils do not contribute to local tissue damage,
but play a key role in skeletal muscle regeneration, in mice injected with
Bothrops asper snake venom. Muscle Nerve. 2003;28(4):449–59.
doi:10.1002/mus.10453.
13. Chazaud B, Sonnet C, Lafuste P, Bassez G, Rimaniol AC, Poron F, et al.
Satellite cells attract monocytes and use macrophages as a support to
Pichavant et al. Skeletal Muscle  (2016) 6:2 Page 8 of 9
escape apoptosis and enhance muscle growth. J Cell Biol. 2003;163(5):1133–43.
doi:10.1083/jcb.200212046.
14. Murphy MM, Lawson JA, Mathew SJ, Hutcheson DA, Kardon G. Satellite cells,
connective tissue fibroblasts and their interactions are crucial for muscle
regeneration. Development. 2011;138(17):3625–37. doi:10.1242/dev.064162.
15. Moss FP, Leblond CP. Satellite cells as the source of nuclei in muscles of
growing rats. Anat Rec. 1971;170(4):421–35. doi:10.1002/ar.1091700405.
16. Crawford GE, Faulkner JA, Crosbie RH, Campbell KP, Froehner SC,
Chamberlain JS. Assembly of the dystrophin-associated protein complex
does not require the dystrophin COOH-terminal domain. J Cell Biol.
2000;150(6):1399–410.
17. Katada S, Nakagawa T, Kataoka H, Touhara K. Odorant response assays for a
heterologously expressed olfactory receptor. Biochem Biophys Res
Commun. 2003;305(4):964–9.
18. Muscat GE, Kedes L. Multiple 5′-flanking regions of the human alpha-skeletal
actin gene synergistically modulate muscle-specific expression. Mol Cell Biol.
1987;7(11):4089–99.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods.
2001;25(4):402–8. doi:10.1006/meth.2001.1262.
20. Pichavant C, Pavlath GK. Incidence and severity of myofiber branching with
regeneration and aging. Skelet Muscle. 2014;4:9. doi:10.1186/2044-5040-4-9.
21. Chan S, Head SI. The role of branched fibres in the pathogenesis of
Duchenne muscular dystrophy. Exp Physiol. 2011;96(6):564–71.
doi:10.1113/expphysiol.2010.056713.
22. Schmalbruch H. The morphology of regeneration of skeletal muscles in the
rat. Tissue Cell. 1976;8(4):673–92.
23. Sadeh M, Czyewski K, Stern LZ. Chronic myopathy induced by repeated
bupivacaine injections. J Neurol Sci. 1985;67(2):229–38.
24. Head SI, Houweling PJ, Chan S, Chen G, Hardeman EC. Properties of
regenerated mouse extensor digitorum longus muscle following notexin
injury. Exp Physiol. 2014;99(4):664–74. doi:10.1113/expphysiol.2013.077289.
25. McGeachie JK, Grounds MD, Partridge TA, Morgan JE. Age-related changes
in replication of myogenic cells in mdx mice: quantitative autoradiographic
studies. J Neurol Sci. 1993;119(2):169–79.
26. Roig M, Roma J, Fargas A, Munell F. Longitudinal pathologic study of the
gastrocnemius muscle group in mdx mice. Acta Neuropathol. 2004;107(1):27–34.
doi:10.1007/s00401-003-0773-3.
27. Chan S, Head SI, Morley JW. Branched fibers in dystrophic mdx muscle are
associated with a loss of force following lengthening contractions. Am J
Physiol Cell Physiol. 2007;293(3):C985–92. doi:10.1152/ajpcell.00128.2007.
28. Hernandez-Ochoa EO, Pratt SJ, Garcia-Pelagio KP, Schneider MF, Lovering
RM. Disruption of action potential and calcium signaling properties in
malformed myofibers from dystrophin-deficient mice. Physiological reports.
2015;3(4). doi:10.14814/phy2.12366.
29. Fukuda N, Yomogida K, Okabe M, Touhara K. Functional characterization
of a mouse testicular olfactory receptor and its role in chemosensing and
in regulation of sperm motility. J Cell Sci. 2004;117(Pt 24):5835–45.
doi:10.1242/jcs.01507.
30. Reynolds JG, McCalmon SA, Donaghey JA, Naya FJ. Deregulated protein
kinase A signaling and myospryn expression in muscular dystrophy. J Biol
Chem. 2008;283(13):8070–4. doi:10.1074/jbc.C700221200.
31. Jiang C, Wen Y, Kuroda K, Hannon K, Rudnicki MA, Kuang S. Notch signaling
deficiency underlies age-dependent depletion of satellite cells in muscular
dystrophy. Dis Model Mech. 2014;7(8):997–1004. doi:10.1242/dmm.015917.
32. Benedetti S, Cossu G, Tedesco FS. Gene and cell therapies for muscular
dystrophies. In: Templeton NS, editor. Gene and cell therapy:
therapeutic mechanisms and strategies. 4th ed. New York: Marcel
Dekker; 2015. p. 993–1015.
33. Guiraud S, Chen H, Burns DT, Davies KE. Advances in genetic therapeutic
strategies for Duchenne muscular dystrophy. Experimental physiology. 2015.
doi:10.1113/EP085308
34. Spehr M, Gisselmann G, Poplawski A, Riffell JA, Wetzel CH, Zimmer RK, et al.
Identification of a testicular odorant receptor mediating human sperm
chemotaxis. Science. 2003;299(5615):2054–8. doi:10.1126/science.1080376.
35. Pluznick JL, Zou DJ, Zhang X, Yan Q, Rodriguez-Gil DJ, Eisner C, et al.
Functional expression of the olfactory signaling system in the kidney. Proc
Natl Acad Sci U S A. 2009;106(6):2059–64. doi:10.1073/pnas.0812859106.
36. Serizawa S, Miyamichi K, Takeuchi H, Yamagishi Y, Suzuki M, Sakano H. A
neuronal identity code for the odorant receptor-specific and activity-
dependent axon sorting. Cell. 2006;127(5):1057–69. doi:10.1016/j.cell.2006.10.031.
37. Imai T, Suzuki M, Sakano H. Odorant receptor-derived cAMP signals
direct axonal targeting. Science. 2006;314(5799):657–61.
doi:10.1126/science.1131794.
38. Robertson TA, Papadimitriou JM, Grounds MD. Fusion of myogenic cells to
the newly sealed region of damaged myofibres in skeletal muscle
regeneration. Neuropathol Appl Neurobiol. 1993;19(4):350–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Pichavant et al. Skeletal Muscle  (2016) 6:2 Page 9 of 9
